基于网络药理学探讨钝顶螺旋藻改善高血压的作用机制研究
To Explore the Mechanism of Spirulina Platensis in Improving Hypertension Based on Network Pharmacology
DOI: 10.12677/pi.2026.154034, PDF,   
作者: 韩 鹏, 李 佳, 梅兴国*:湖北科技学院医学部药学院,湖北 咸宁;湖北康健医药科技有限公司,湖北 咸宁;王凯迪:湖北科技学院医学部药学院,湖北 咸宁
关键词: 螺旋藻有效成分高血压网络药理学Spirulina Effective Components Hypertension Network Pharmacology
摘要: 目的:采用网络药理学筛选螺旋藻活性成分,寻找其改善高血压的核心靶点,探讨作用机制。方法:通过文献及SWISS Target Prediction数据库筛选螺旋藻活性成分及作用靶点;以“Hypertension”为关键词从GeneCards、OMIM、Drugbank和TTD数据库中检索疾病靶点,取交集,构建PPI网络;通过DAVID进行GO和KEGG分析,利用Cytoscape 构建成分–靶点–通路图。结果:共获得螺旋藻活性成分相关靶点754个,203个靶点与高血压相关,SRC、CTNNB1、EGFR、STAT3、TP53、AKT1、PIK3CA、CYP3A4等核心靶点;通过GO和KEGG分析收集到836条BP、88条CC、188条MF条目,167条KEGG信号通路。结论:本研究体现了螺旋藻有效成分可改善高血压作用,为后续机制验证实验指明了方向。
Abstract: Objective: To screen the active components of spirulina by network pharmacology, to find the core targets for improving hypertension, and to explore the mechanism of action. Methods: The active components and targets of spirulina were screened by literature and SWISS Target Prediction database. The disease targets were retrieved from GeneCards, OMIM, Drugbank and TTD databases with ‘Hypertension’ as the key word, and the intersection was taken to construct the PPI network. GO and KEGG analysis were performed by DAVID, and the component-target-pathway diagram was constructed by Cytoscape. Results: 754 gene targets were obtained from the effective components of spirulina, and 203 targets were related to hypertension, such as SRC, CTNNB1, EGFR, STAT3, TP53, AKT1, PIK3CA, CYP3A4 and other core targets. Through GO and KEGG analysis, 836 BP, 88 CC, 188 MF items and 167 KEGG signaling pathways were collected. Conclusion: This study shows that the effective components of spirulina can improve hypertension, and points out the direction for subsequent mechanism verification experiments.
文章引用:韩鹏, 王凯迪, 李佳, 梅兴国. 基于网络药理学探讨钝顶螺旋藻改善高血压的作用机制研究[J]. 药物资讯, 2026, 15(4): 321-329. https://doi.org/10.12677/pi.2026.154034

参考文献

[1] 万琪琪, 徐朝辉, 杨佳慧, 等. 利肾降压方对自发性高血压模型大鼠的心肾保护作用[J/OL]. 中国实验方剂学杂志, 1-18. 2026-05-04.[CrossRef
[2] Talle, M.A., Ngarande, E., Doubell, A.F., et al. (2023) Prevalence of Myocardial Injury and Myocardial Infarction in Patients with a Hypertensive Emergency: A Systematic Review. Diagnostics, 13, Article 60. [Google Scholar] [CrossRef] [PubMed]
[3] Kelly, D.M. and Rothwell, P.M. (2020) Blood Pressure and the Brain: The Neurology of Hypertension. Practical Neurology, 20, 100-108.
[4] 陈志桃, 王立兴, 林维钦, 等. 螺旋藻藻蓝蛋白的研究进展[J]. 海峡药学, 2003, 15(6): 1-5.
[5] 孙鹏, 胡君艳, 李瑞强. 螺旋藻多糖的结构及生物学活性研究[J]. 中国生化药物杂志, 2005, 26(3): 185-187.
[6] 于红. 钝顶螺旋藻多糖抗病毒及抗肿瘤作用的研究[D]: [博士学位论文]. 青岛: 中国海洋大学, 2003.
[7] 谌倩. 钝顶螺旋藻营养组分的分离及抗氧化活性研究[D]: [硕士学位论文]. 南昌: 南昌大学, 2022.
[8] 部音利, 冯亚非. 螺旋藻中生物活性物质的药理作用研究进展[C]//中国药学会, 河北省人民政府. 2008年中国药学会学术年会暨第八届中国药师周论文集. 湛江: 广东海洋大学食品科技学院, 2008: 1631-1637.
[9] Firdaus, M. and Priambodo, F.A. (2025) Impact of Spirulina Supplementation on Obesity, Hypertension, Hyperglycemia, and Hyperlipidemia: A Systematic Review. Scientifica, 2025, Article ID: 6637793. [Google Scholar] [CrossRef] [PubMed]
[10] 任茂佳, 宋晓鹏, 贺文帅, 等. 沙库巴曲缬沙坦钠治疗高血压合并HFpEF的效果及对血压控制达标率、血压变异性的影响[J]. 中国循证心血管医学杂志, 2025, 17(7): 816-819.
[11] 中国高血压防治指南修订委员会, 高血压联盟(中国), 中国医疗保健国际交流促进会高血压病学分会, 等. 中国高血压防治指南(2024年修订版) [J]. 中华高血压杂志(中英文), 2024, 32(7): 603-700.
[12] 刘艺轩, 王可馨, 王文杰, 等. C反应蛋白-甘油三酯-葡萄糖指数与中老年高血压风险的关系研究[J]. 中国医药, 2026, 21(4): 481-485.
[13] Zhou, B., Perel, P., Mensah, G.A., et al. (2021) Global Epidemiology, Health Burden and Effective Interventions for Elevated Blood Pressure and Hypertension. Nature Reviews Cardiology, 18, 785-802. [Google Scholar] [CrossRef] [PubMed]
[14] Mc Evoy, J.W., Mc Carthy, C.P., Bruno, R.M., et al. (2024) ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension. European Heart Journal, 45, 3912-4018. [Google Scholar] [CrossRef] [PubMed]
[15] Chauhan, D., Mehla, K., Nair, A., et al. (2012) Spirulian Reverses Histomorphological Changes Indiabetic Osteoporosis in Pioglitazone Treated Rats. Journal of Diabetes and Metabolism, 1-7.
[16] Gogna, S., Kaur, J., Sharma, K., et al. (2023) Spirulina—An Edible Cyanobacterium with Potential Therapeutic Health Benefits and Toxicological Consequences. Journal of the American Nutrition Association, 42, 559-572. [Google Scholar] [CrossRef] [PubMed]
[17] 杨晓岚. 螺旋藻的药理研究和临床辅助应用[J]. 中国民族民间医药, 2009, 18(10): 9.
[18] 崔红霞, 张晓东, 七十三, 乌力吉, 成海荣, 哈斯牧仁, 刘光瑞, 张楠. 螺旋藻的营养功能及其在畜禽生产中的应用[J]. 畜牧兽医杂志, 2026, 45(1): 89-95.